In 2024 (the year from HELL), Pfizer integrated SeaGen and in October allowed ZS associates to needlessly disrupt so many territories / lives. Reps were told stay focused, stay the course, sell more. Leadership brought back area of the year award to incentivize everyone. In years past, this was...
Sadly is u report harassment, racism etc, u will be left dismissed and belittled and they do not address it. They cover it up
Proof is there. I mean a lot of proof . And witnesses too. and they instead make u feel like you are insane and now you are on the way out. Best next steps? I have a...
I am in R&D (PRD, remote approved, GT site). Has anyone heard anything from your managers on whether you are impacted?
also I thought PGS mfg sites was not going to be impacted but saw news about Kalamazoo 200 head count news today
It would be great for some of us to share our thoughts and feelings regarding the cuts in the PAXLOVID/Comirnaty/Prevnar/Lucira contract. I feel that there were lies and misrepresentation regarding the situation up until the fateful Friday calls. How about you?
I am considering a position as a sales rep with Pfizer. Can anyone share what resources are currently being made available to employees (iPad model, other technology, etc.) and what your experience has been like over the last few years? How many calls/interactions are you expected to make per...
The poor bedraggled Internal Medicine team. Two years ago at this time we had 3 - count em, 3 IM teams. First it was Team 3; gone. A year later all of Team 1. Now it's Team 2's turn. My question is - how many people are left in IM? I'm in a different division now but still get IM emails so...
Mylan N.V. (MYL) reported its financial results for the quarter ended March 31, 2020, on Monday before the market opens. The company reaffirmed its financial guidance for the full-year 2020.
The results were driven by overall volume growth, which was favorably impacted by increased customer...
Total revenues declined 5% year-over-year to $12.68 billion from $13.3 billion in the third quarter of 2018.
Segment-wise, Biopharma revenues grew 7% annually to $10.1 billion, while Upjohn revenues dropped 26% to $2.19 billion. Consumer Healthcare revenues were down 55%.
Pfizer management...
Novo Nordisk says pricing pressure within diabetes to continue, especially in the US.
First quarter 2019 results: Sales from North America Operations declined 4% on constant exchange rates.
Pfizer (PFE) reported a better-than-expected 2% increase in fourth-quarter revenues to $13.9 billion. Earnings rose to 64 cents per share from 62 cents per share a year ago, surpassing analysts’ estimate of 63 cents per share.
PFE shares were down 3% during pre-market trading on Tuesday. Shares...